2型糖尿病中的性激素与心血管风险:Look AHEAD试验队列研究
该前瞻性队列研究基于Look AHEAD试验,纳入2,260例2型糖尿病成人,检测基线和1年生活方式干预后的性激素及性激素结合球蛋白(SHBG),按性别特异性三分位分组分析其与心血管事件(488例事件)的关联及减重交互作用。结果显示,在男性中,基线总睾酮较高与较低心血管风险相关,减重≥7%时SHBG升高与较低风险相关,减重<7%时雌二醇升高与较高风险相关;女性中未发现关联。
要点
- 男性2型糖尿病患者基线总睾酮较高与心血管风险降低相关(HR=0.74,95%CI 0.56-0.97)。
- 男性减重≥7%时,SHBG升高与心血管风险降低相关(HR=0.47,95%CI 0.26-0.85)。
- 男性减重<7%时,雌二醇升高与心血管风险增加相关;女性中未发现关联。
核心结论
- 在男性2型糖尿病患者中,性激素与心血管事件相关,而女性中未观察到关联。
研究设计与样本
- 前瞻性队列研究,基于Look AHEAD试验,纳入2,260例2型糖尿病成人,检测基线和1年性激素及SHBG,按性别特异性三分位分组分析。
主要发现
- 男性基线总睾酮较高与较低心血管风险相关(HR=0.74;95%CI 0.56-0.97)。
- 男性减重≥7%时,SHBG升高与较低心血管风险相关(HR=0.47;95%CI 0.26-0.85)。
- 男性减重<7%时,雌二醇第二三分位较第一三分位心血管风险HR=1.64(95%CI 1.13-2.38),第三三分位较第一三分位HR=1.88(95%CI 1.29-2.73)。
- 女性中未检测到性激素与心血管事件的关联。
临床怎么用
- 在男性2型糖尿病患者中,评估性激素水平可能有助于心血管风险分层,尤其结合减重幅度解读SHBG和雌二醇变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the association of sex hormones at baseline and 1 year after a lifestyle intervention on cardiovascular (CV) risk in type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: This prospective study, following the Look AHEAD: Action for Health in Diabetes (Look AHEAD) trial, of 2,260 adults with T2D, included measurements of sex hormones and sex hormone binding globulin (SHBG). Baseline levels and 1-year changes were divided into sex-specific tertiles to assess the association with CV events (n = 488 events) and weight loss interactions. RESULTS: In men, higher baseline total testosterone was associated with lower CV risk (hazard ratio [HR] = 0.74; 95% CI 0.56-0.97). In men with ≥7% weight loss, SHBG increases were inversely associated with CV risk (HR = 0.47; 95% CI 0.26-0.85). In men with <7% weight loss, increases in estradiol were associated with CV risk (second vs. first estradiol tertile: HR = 1.64 [95% CI 1.13-2.38]; third vs. first estradiol tertile: HR = 1.88 [95% CI 1.29-2.73]). No associations were detected in women. CONCLUSIONS: In men with T2D, but not women with T2D, sex hormones were associated with CV events.
引用
- Gisinger T, He JH, Oyeka CP, et al. Sex Hormones and Cardiovascular Risk in Type 2 Diabetes: Cohort Study of the Look AHEAD Trial. Diabetes Care. 2026. PMID: 41582527. doi:10.2337/dc25-2465
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。